Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Vegzelma
Descriptions
Bevacizumab-adcd injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum.
Bevacizumab-adcd injection is also used together with other medicines (eg, carboplatin and paclitaxel) to treat nonsquamous, non-small cell lung cancer (NSCLC) that has spread, come back, or cannot be removed by surgery. It is also used to treat a type of brain tumor called glioblastoma that keeps coming back (recurrent).
Bevacizumab-adcd injection also used in combination with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body.
Bevacizumab-adcd injection also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan, carboplatin and paclitaxel, or carboplatin and gemcitabine followed by Vegzelma™ alone) to treat platinum-resistant recurrent (cancer that keeps coming back) or stage 3 or 4 epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who have received 2 previous treatments or with or without surgery.
Bevacizumab-adcd is an antineoplastic that helps the body fight cancer. It prevents the growth of certain types of blood vessels to cancer cells. This helps decrease the growth of cancer cells by starving them of the nutrients they need to grow.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.